HOT NEWS
Novartis
NovartisNovartis AG provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group's continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 97,000 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

Novartis RSS Channel

Title Filter     Display # 
# Article Title Hits
1 Novartis receives EU approval for Ilaris® in patients suffering acute gouty arthritis attacks 2000
2 Novartis drug Votubia® approved as first medication to treat patients with non-cancerous kidney tumors associated with TSC 4059
3 Novartis receives European Commission approval for once-daily Seebri® Breezhaler® as maintenance COPD treatment 3312
4 Novartis data at ERS shows efficacy of once-daily COPD portfolio versus comparators 3054
5 Afinitor® approved by European Commission to treat patients with the most common form of advanced breast cancer 3653
6 CHMP recommends Novartis drug Afinitor® for EU approval 3885
7 Novartis drug Signifor® approved in the EU as the first medication to treat patients with Cushing's disease 4762
8 Novartis QVA149 Phase III COPD studies meet primary endpoints 4492
9 European Commission approves new label for Novartis drug Glivec® 8647
10 Novartis to revise product information in the European Union for high blood pressure drug Rasilez® following assessment by CHMP 4651
11 Novartis drug Signifor® recommended by CHMP for EU approval 4518
12 Novartis Foundation symposium looks at impact of Information and Communication Technology 6373
13 Novartis gains European Commission approval for Rasitrio® 5058
14 Novartis associates participate in first company-wide health and well-being initiative 4858
15 Novartis drug Afinitor® gains EU approval to treat patients with advanced pancreatic neuroendocrine tumors 5136
16 Novartis drug Afinitor® recommended by CHMP 5466
17 Novartis delivers strong financial results and four major approvals 5333
18 Novartis drug Afinitor® met primary endpoint of Phase III study in women with advanced breast cancer 5891
19 Novartis drug Votubia® recommended by CHMP for approval in the EU 5936
20 Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia 6480
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  Next 
  •  End 
  • »
Page 1 of 4